Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

25 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

367

146 (4%)

70 (29%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185961
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185964
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-10-20 2023-11-06 207683
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Actual shortage 2025-03-13 2025-04-17 252564
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-SOTALOL 80MG TABLET Resolved 2023-01-06 2023-02-16 180086
APO-SOTALOL 160MG TABLET Resolved 2023-01-06 2023-02-16 180093
APO-SOTALOL 160MG TABLET Resolved 2023-03-09 2023-06-29 186569
APO-SOTALOL 80MG TABLET Resolved 2023-04-14 2023-06-29 189635
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TICAGRELOR 60MG TABLET To be discontinued 2025-11-12 2025-11-20 257700
APO-TICAGRELOR 60MG TABLET Discontinued 2025-11-19 2025-11-20 257747
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-TIMOP OPH SOLN 0.25% Discontinued 2019-01-02 2019-01-02 70818
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-TRAZODONE TABLETS 100MG 100MG TABLET Discontinued 2018-09-08 2018-09-15 60831
APO-TRAZODONE TABLETS 50MG 50MG TABLET Discontinued 2018-09-08 2018-09-15 60834
APO-VALACYCLOVIR 500MG TABLET Discontinued 2018-09-08 2018-09-15 60840
APO-VALGANCICLOVIR 450MG TABLET Discontinued 2018-09-08 2018-09-15 60843
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051